| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/15/2005 | EP1539214A2 Thrombin peptide derivatives |
| 06/15/2005 | EP1539213A2 Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase |
| 06/15/2005 | EP1539211A2 Method of up-regulating tumor antigen expression using thymalfasin |
| 06/15/2005 | EP1539210A2 Modified glp-1 receptor agonists and their pharmacological methods of use |
| 06/15/2005 | EP1539208A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 06/15/2005 | EP1539207A1 Treatment of cell proliferative disorders with chlorotoxin |
| 06/15/2005 | EP1539206A1 Cosmetic or dermatological preparations having a content of anti-freezing proteins and/or anti-freezing glycoproteins |
| 06/15/2005 | EP1539204A1 Plant extracts for treatment of angiogenesis and metastasis |
| 06/15/2005 | EP1539198A2 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/15/2005 | EP1539190A1 Biosynthesis of hif |
| 06/15/2005 | EP1539188A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 06/15/2005 | EP1539177A2 Compositions and methods for treating heart disease |
| 06/15/2005 | EP1539170A2 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
| 06/15/2005 | EP1539142A2 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer s disease |
| 06/15/2005 | EP1539131A2 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 06/15/2005 | EP1539107A2 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 06/15/2005 | EP1539106A2 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 06/15/2005 | EP1539103A2 Methods of treating idiopathic pulmonary fibrosis |
| 06/15/2005 | EP1539097A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
| 06/15/2005 | EP1539041A1 Devices delivering therapeutic agents and methods regarding the same |
| 06/15/2005 | EP1539023A2 Treatment of multiple sclerosis with brain targeted anti oxidant compounds |
| 06/15/2005 | EP1538900A2 Cancer vaccines containing epitopes of oncofetal antigen |
| 06/15/2005 | EP1439831B1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 06/15/2005 | EP1435975A4 Methods of using 279, a human g protein-coupled receptor |
| 06/15/2005 | EP1373240B1 Retinoid x receptor modulators |
| 06/15/2005 | EP1349566A4 Methods for ameliorating childhood infections |
| 06/15/2005 | EP1309625B1 Therapeutic compounds for ovarian cancer |
| 06/15/2005 | EP1278530B1 Chemical modification of mammalian urine |
| 06/15/2005 | EP1276496B1 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/15/2005 | EP1268519B1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/15/2005 | EP1257566A4 Method of treating disorders of the eye |
| 06/15/2005 | EP1248836B1 Method for preparing vaccines by using hybrid cells |
| 06/15/2005 | EP1212420B1 Conditional immortalisation of cells |
| 06/15/2005 | EP1198255A4 Identification of compounds that modify transcriptional responses to hypoxia |
| 06/15/2005 | EP1165070B1 Thiadiazolyl urea or thiourea derivatives for antiviral treatment |
| 06/15/2005 | EP1075282B1 Peg-lhrh analog conjugates |
| 06/15/2005 | EP1075270B1 Short peptide for treatment of neurological degenerative diseases |
| 06/15/2005 | EP1072608B1 Glutathione derivatives and dosage forms thereof |
| 06/15/2005 | EP1066059B1 Formulations for protection of peg-interferon alpha conjugates |
| 06/15/2005 | EP1066050B1 Application of hsp70 proteins |
| 06/15/2005 | EP1062348B1 Recombinant onconase and fusion proteins of recombinant onconase |
| 06/15/2005 | EP1012338B1 A tumor suppressor designated ts10q23.3 |
| 06/15/2005 | EP1007068B1 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 06/15/2005 | EP1005359B1 FRACTURE HEALING USING PTHrP ANALOGS |
| 06/15/2005 | EP1001979B1 Cyclic azapeptides with angiogenic effect |
| 06/15/2005 | EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) |
| 06/15/2005 | EP0996732B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 06/15/2005 | EP0979099B1 Use of lactoferin in the treatment of allergen induced disorders |
| 06/15/2005 | EP0969866B1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 06/15/2005 | EP0964695B1 Methods and compositions for treating pain |
| 06/15/2005 | EP0956031B1 Inhibition of 26 s and 20 s proteasome by indanones |
| 06/15/2005 | EP0954602B1 Hereditary hemochromatosis gene |
| 06/15/2005 | EP0885241B1 Purification method |
| 06/15/2005 | EP0855915B1 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases |
| 06/15/2005 | EP0734247B2 Cosmetic and/or pharmaceutical preparations |
| 06/15/2005 | CN1628128A Mammal prolactin variants |
| 06/15/2005 | CN1628126A Modified transferrin fusion proteins |
| 06/15/2005 | CN1627959A Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| 06/15/2005 | CN1627958A Immunocytokine-containing lyophilized preparation |
| 06/15/2005 | CN1626655A Synthetase-1b for human cholesterol ester and coded sequence |
| 06/15/2005 | CN1626566A Process for the removal of porogens from temperature sensitive macroreticular polymers using steam at reduced pressure |
| 06/15/2005 | CN1626554A Interfusion protein between human serum albumin and interleukin, and encoding genes |
| 06/15/2005 | CN1626552A Angiogenesis related molecules |
| 06/15/2005 | CN1626549A Carbowax alcoholized ramification of TimopEntin, combination of medication and application |
| 06/15/2005 | CN1626548A Protein purification by ion exchange chromatography |
| 06/15/2005 | CN1626547A Protein purification by ion exchange chromatography |
| 06/15/2005 | CN1626544A Expressing Ompk antigen of outer-membrane protein of Vibrio Harveyi and application as constituent of bacterin |
| 06/15/2005 | CN1626243A Sustained release ionic conjugate |
| 06/15/2005 | CN1626240A Antigen-specific lgE antibody production inhibitors |
| 06/15/2005 | CN1626239A Use of TGF-beta and growth factor in treatment and prevention of intestinal mucosa diseases |
| 06/15/2005 | CN1626238A Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
| 06/15/2005 | CN1626237A Antibiosis usage of a family of protein |
| 06/15/2005 | CN1626235A Compound preparation of forest frog, and preparation method |
| 06/15/2005 | CN1626070A Effect of aminoguanidine for curing wound surface in refractory to treatment |
| 06/15/2005 | CN1625965A Soluble soy protein with superior functional properties |
| 06/15/2005 | CN1625964A Capsule of natural protein containing selenium and American ginseng |
| 06/15/2005 | CN1625963A Capsule of natural protein containing selenium and root of pilose asiabell |
| 06/15/2005 | CN1206353C Preparation method of beta cyclodextrin carthworm plasmin modification enzyme |
| 06/15/2005 | CN1206343C Pseudomycin production by i(pseudomonas syringae) |
| 06/15/2005 | CN1206242C Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/15/2005 | CN1206241C Novel natural antibacterial peptide, its code sequence and application |
| 06/15/2005 | CN1206239C Cyclohexapeptides and their mixtures, process for preparing them, and their use |
| 06/15/2005 | CN1206237C Low allergenic proteinvariants |
| 06/15/2005 | CN1205998C Antigen-specific IgE antibody production inhibitors |
| 06/15/2005 | CN1205997C Method of increasing bone toughness and stiffness and reducing fractures |
| 06/15/2005 | CN1205996C Mannan peptide freeze dried pwoder ampoule for injection |
| 06/15/2005 | CN1205995C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 06/15/2005 | CN1205994C Pulmonary delivery of active agents |
| 06/14/2005 | US6906186 Hydride nucleic acid |
| 06/14/2005 | US6906182 Inhibiting abnormal cellular proliferation in a mammal; and a method of inhibiting replication of a virus in a mammal. |
| 06/14/2005 | US6906179 Antibody to SNIP1 |
| 06/14/2005 | US6906177 Screening; psychological disorders, brain disorders, antiepileptic agents; genetic engineering |
| 06/14/2005 | US6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof |
| 06/14/2005 | US6906169 Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide |
| 06/14/2005 | US6906106 Compositions for the skin comprising fibers and ubiquinones and methods of using the same |
| 06/14/2005 | US6906056 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/14/2005 | US6906041 Treatment of immune diseases |
| 06/14/2005 | US6906037 Therapeutic peptide-based constructs |
| 06/14/2005 | US6906036 Anti-aging and wound healing compounds |
| 06/14/2005 | US6906035 Useful for inhibiting microbial infection or growth, as well reducing the effects of endotoxemia |